亚洲社会药学

本期目录

2016年, 第11卷, 第3期　刊出日期：2016-09-20 上一期    下一期

论文

Select

Strategic Research on Enhancing China’s Cooperation with International Organizations in Drug Supervision Yuan Lin, Shao Mingli 2016 (3):  89-95.  摘要 ( 309 )   PDF(430KB) ( 362 )   Objective To strengthen the cooperation between Chinese government and international organizations to ensure drug safety and promote the development of pharmaceutical industry. Methods Some international organizations in pharmaceutical industry were selected and studied according to dimensions such as their internationalization level, nature, activity contents, and Chinese government participation level, so as to promote the cooperation. Results and Conclusion Specific policy measures are raised to enhance international cooperation between China and international organizations. 相关文章 | 计量指标

Select

Discussion on Management of Expert Conflicts of Interest in Drug Evaluation Process Chen Taohui, Zhang Xianglin 2016 (3):  96-101.  摘要 ( 364 )   PDF(397KB) ( 295 )   Objective To explore the concept of expert conflicts of interest in drug evaluation process and the necessity to manage conflicts of interest, and to propose suggestions for regulating expert conflicts of interest in China by learning from experience of drug regulatory authorities in foreign countries. Methods Comparative method was used to study the management of expert conflicts of interest in drug evaluation process in Europe, the United States and China. Results and Conclusion FDA and EU attach great importance to the role of experts in drug evaluation process, and they also cope with the problems of expert conflicts of interest successfully. In contrast, there are some problems in drug evaluation process in China. Therefore, it is necessary to strengthen the transparency of evaluation process to avoid expert conflicts of interest and ensure the impartiality and scientific nature of their opinions. 相关文章 | 计量指标

Select

Characteristics of Pharmaceutical Enterprises Distribution in Yunnan Province and Its Relationship with Regional Industrial Economy Song Yi, Wang Quan, Zhang Jun, Su Siyin, Kong Fanjian 2016 (3):  102-106.  摘要 ( 345 )   PDF(905KB) ( 364 )   Objective To better manage the development of pharmaceutical industry in Yunnan Province. Methods Cluster analysis and discriminant analysis were used to study the characteristics of pharmaceutical enterprises distribution. And Pearson correlation analysis was applied to analyze the relationship between the economic data of pharmaceutical enterprises and regional industrial economy. Results and Conclusion Thirteen cities in Yunnan Province are classified into four levels according to the scales of pharmaceutical industry, while most of pharmaceutical enterprises are located in Kunming. The revenue and profit of pharmaceutical enterprises mainly come from technical innovation which is based on talents’ contribution. However, majority of talents prefer to settle in Kunming and that eventually leads to unbalanced regional development. 相关文章 | 计量指标

Select

Accumulation and Utilization Status of Medicare Data in Taiwan from the Perspective of Pharmacoeconomic Evaluation Lu Yan, Duan Xiaomin, Ren Xiaoxiao, Sun Lihua 2016 (3):  107-111.  摘要 ( 300 )   PDF(370KB) ( 325 )   Objective To improve Medicare database and the efficiency of data utilization from pharmacoeconomic evaluation perspective in China by studying and learning from the accumulation and utilization practices of Medicare data in Taiwan. Methods Literature and comparative studies were conducted to introduce the utilization status of Medicare database in China and to analyze National Health Insurance Research Databases (NHIRD) systematically. Results and Conclusion Some suggestions are put forward: (1) perfecting data structure, standardizing database and increasing the completeness and the accuracy of the data; (2) improving the corresponding legal provisions, setting up data application procedures to enhance the efficiency of data obtaining and utilizing. 相关文章 | 计量指标

Select

Impact of Big Medical Data on Medical Record Data Formation Model from Pharmacoeconomic Evaluation Perspectives Duan Xiaomin, Lu Yan, Sun Lihua 2016 (3):  112-115.  摘要 ( 292 )   PDF(346KB) ( 374 )   Objective To analyze the impact of big medical data on medical record data formation model. Methods Literature review was conducted to study the formation status of the data the pharmacoeconomic evaluation needed in hospital medical records, and to explore the impact of big medical data on the data, needed in pharmacoeconomic evaluation. Results and Conclusion Big medical data can help to achieve the collection and measurement of intangible costs and indirect costs, realize information resource sharing, weaken the relationship between the accuracy of the data and the accuracy of the evaluation results, and to improve patients’ compliance. It is expected that big medical data can help to reform the formation model of hospital medical record data and to create more data the pharmacoeconomic evaluation or relevant research needed. 相关文章 | 计量指标

Select

Analysis on the Status of Essential Medicines Used in Community Health Institutions in Beijing Yang Yu, Li Shuchuan, Zhang Fang 2016 (3):  116-122.  摘要 ( 369 )   PDF(428KB) ( 300 )   Objective To evaluate the status of essential medicines used in community health institutions in Beijing from 2 perspectives: essential medicine storage and the problems in the use of essential medicines, and to raise some suggestions. Methods Survey methods was applied to study the types of essential medicines in community health institutions, their average expenses, the storage status and existing problems in the use of essential medicines. Results and Conclusion Community health institutions are storing about 377 types of essential medicines, covering 53.9% of the essential medicines list in Beijing, and averagely 61.6% of the total essential medicines list. The average drug expenses per outpatient increased year by year from 2009 to 2013. Both the types and supply of essential medicines can’t meet the clinical need of patients at community health centers. First-aid and low-priced essential medicines are out of stock. Some patients are doubtful about the brands and quality of essential medicines. It is suggested that more commonlyused drugs for chronic diseases should be added to the essential medicines directory and drug centralized bidding mechanism should be improved as well. Coordinated efforts and support from physicians and pharmacists in large hospitals would be needed. With the help of good policy planning, the existing problems will be solved in essential medicines use. 相关文章 | 计量指标

Select

Study on Pharmacy Undergraduate Talents Training Target —Taking Shenyang Pharmaceutical University as an Example Hou Chunli, Wu Zhi’ang, Dong Xiaoli 2016 (3):  123-127.  摘要 ( 351 )   PDF(389KB) ( 329 )   Objective To study the target of pharmacy undergraduate talents training. Methods Literature review was used to redefine the concept of talents; case study method was also applied by choosing pharmacy students from Shenyang Pharmaceutical University as the research objects; and data analysis was conducted to explore the areas of employment for pharmacy undergraduates. Results and Conclusion It can be found from the research that most of pharmacy undergraduates get jobs in drug research and development (R&D), pharmaceutical production management and drug quality control areas. Therefore, it is suggested that the target of pharmacy undergraduate talents training should focus on motivating students to be competent for drug R&D, pharmaceutical production management and drug quality control areas in the future. 相关文章 | 计量指标